#Daraxonrasib

1 articles

A highly detailed medical illustration showing a cancer cell being targeted and blocked by a modern

New Dawn in Pancreatic Cancer Treatment: Clinical Breakthrough of Daraxonrasib

A new oral drug, Daraxonrasib, has shown significant potential in clinical trials, nearly doubling survival times for patients with advanced RAS-mutated pancreatic cancer.

Williams·Jun 1, 2026·2 min read